Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis

How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?

(2014) W. F. Anderson et al.   JNCI-Journal of the National Cancer Institute

CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways

(2014) Tammy Sobolik et al.   MOLECULAR BIOLOGY OF THE CELL

Molecular tests as prognostic factors in breast cancer

(2014) Marc J. van de Vijver   VIRCHOWS ARCHIV

Mutation of POLB Causes Lupus in Mice

(2014) Alireza G. Senejani et al.   Cell Reports

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)

(2013) H. Nitta et al.   CLINICAL CANCER RESEARCH

Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer

(2013) Jie Gu et al.   LUNG CANCER

The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo

(2013) Xiaoyang Ling et al.   PLoS One

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

(2013) M. Gil et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression

(2012) Leticia Corrales et al.   JOURNAL OF IMMUNOLOGY

Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer

(2012) Mutsuko Yamamoto-Ibusuki et al.   MODERN PATHOLOGY

Targeted therapies for breast cancer

(2011) Michaela J. Higgins et al.   JOURNAL OF CLINICAL INVESTIGATION

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model

(2010) Saima Hassan et al.   INTERNATIONAL JOURNAL OF CANCER

CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression

(2010) Xiaojuan Sun et al.   Molecular Cancer

Triple-negative breast cancer: disease entity or title of convenience?

(2010) Lisa Carey et al.   Nature Reviews Clinical Oncology

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

(2009) Hirotaka Iwase et al.   Breast Cancer

Modulation of the antitumor immune response by complement

(2008) Maciej M Markiewski et al.   NATURE IMMUNOLOGY